These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37272616)

  • 1. Allele-specific gene-editing approach for vision loss restoration in
    Liu X; Qiao J; Jia R; Zhang F; Meng X; Li Y; Yang L
    Elife; 2023 Jun; 12():. PubMed ID: 37272616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal degeneration in humanized mice expressing mutant rhodopsin under the control of the endogenous murine promoter.
    Liu X; Jia R; Meng X; Li Y; Yang L
    Exp Eye Res; 2022 Feb; 215():108893. PubMed ID: 34919893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.
    Du W; Li J; Tang X; Yu W; Zhao M
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1818-1828. PubMed ID: 37837380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model.
    Patrizi C; Llado M; Benati D; Iodice C; Marrocco E; Guarascio R; Surace EM; Cheetham ME; Auricchio A; Recchia A
    Am J Hum Genet; 2021 Feb; 108(2):295-308. PubMed ID: 33508235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cas9/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery.
    Giannelli SG; Luoni M; Castoldi V; Massimino L; Cabassi T; Angeloni D; Demontis GC; Leocani L; Andreazzoli M; Broccoli V
    Hum Mol Genet; 2018 Mar; 27(5):761-779. PubMed ID: 29281027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3.
    Diakatou M; Dubois G; Erkilic N; Sanjurjo-Soriano C; Meunier I; Kalatzis V
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR DNA Base Editing Strategies for Treating Retinitis Pigmentosa Caused by Mutations in
    Kaukonen M; McClements ME; MacLaren RE
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene augmentation for adRP mutations in RHO.
    Lewin AS; Rossmiller B; Mao H
    Cold Spring Harb Perspect Med; 2014 Jul; 4(9):a017400. PubMed ID: 25037104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-7 ablation modulates UPR, reprograms TRAF2-JNK apoptosis and protects T17M rhodopsin mice from severe retinal degeneration.
    Choudhury S; Bhootada Y; Gorbatyuk O; Gorbatyuk M
    Cell Death Dis; 2013 Mar; 4(3):e528. PubMed ID: 23470535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling autosomal dominant retinitis pigmentosa by using patient-specific retinal organoids with a class-3 RHO mutation.
    Lin X; Liu ZL; Zhang X; Wang W; Huang ZQ; Sun SN; Jin ZB
    Exp Eye Res; 2024 Apr; 241():109856. PubMed ID: 38479725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
    Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
    Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis Pigmentosa.
    Burnight ER; Wiley LA; Mullin NK; Adur MK; Lang MJ; Cranston CM; Jiao C; Russell SR; Sohn EH; Han IC; Ross JW; Stone EM; Mullins RF; Tucker BA
    CRISPR J; 2023 Dec; 6(6):502-513. PubMed ID: 38108516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
    Meng D; Ragi SD; Tsang SH
    Mol Ther; 2020 Oct; 28(10):2139-2149. PubMed ID: 32882181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice.
    Mao H; Gorbatyuk MS; Rossmiller B; Hauswirth WW; Lewin AS
    Hum Gene Ther; 2012 Apr; 23(4):356-66. PubMed ID: 22289036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa.
    Occelli LM; Zobel L; Stoddard J; Wagner J; Pasmanter N; Querubin J; Renner LM; Reynaga R; Winkler PA; Sun K; Marinho LFLP; O'Riordan CR; Frederick A; Lauer A; Tsang SH; Hauswirth WW; McGill TJ; Neuringer M; Michalakis S; Petersen-Jones SM
    Mol Ther; 2023 Jul; 31(7):2028-2041. PubMed ID: 37056049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa.
    Bakondi B; Lv W; Lu B; Jones MK; Tsai Y; Kim KJ; Levy R; Akhtar AA; Breunig JJ; Svendsen CN; Wang S
    Mol Ther; 2016 Mar; 24(3):556-63. PubMed ID: 26666451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.
    Zhang X; Girardot PE; Sellers JT; Li Y; Wang J; Chrenek MA; Wu W; Skelton H; Nickerson JM; Pardue MT; Boatright JH
    Mol Vis; 2019; 25():462-476. PubMed ID: 31523123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.
    Wu WH; Tsai YT; Huang IW; Cheng CH; Hsu CW; Cui X; Ryu J; Quinn PMJ; Caruso SM; Lin CS; Tsang SH
    Mol Ther; 2022 Apr; 30(4):1407-1420. PubMed ID: 35150888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease modeling and pharmacological rescue of autosomal dominant retinitis pigmentosa associated with
    Kandoi S; Martinez C; Chen KX; Mehine M; Reddy LVK; Mansfield BC; Duncan JL; Lamba DA
    Elife; 2024 Apr; 12():. PubMed ID: 38661530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
    Sun X; Liang C; Chen Y; Cui T; Han J; Dai M; Zhang Y; Zhou Q; Li W
    Hum Gene Ther; 2024 Mar; 35(5-6):151-162. PubMed ID: 38368562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.